发明公开
EP1655022A1 REMEDY OR DIAGNOSTIC FOR INFLAMMATORY DISEASE CONTAINING TARGET-DIRECTING LIPOSOME
审中-公开
手段治疗或炎症性疾病的诊断与靶向脂质体
- 专利标题： REMEDY OR DIAGNOSTIC FOR INFLAMMATORY DISEASE CONTAINING TARGET-DIRECTING LIPOSOME
- 专利标题（中）： 手段治疗或炎症性疾病的诊断与靶向脂质体
-
申请号： EP04771330.0申请日： 2004-07-30
-
公开(公告)号： EP1655022A1公开(公告)日： 2006-05-10
- 发明人: YAMAZAKI, Noboru , SURUSHIMA, Hideo , OOGURO, Nobuyuki
- 申请人： National Institute of Advanced Industrial Science and Technology
- 申请人地址： 3-1, Kasumigaseki 1-chome, Chiyoda-ku Tokyo 100-8921 JP
- 专利权人： National Institute of Advanced Industrial Science and Technology
- 当前专利权人： National Institute of Advanced Industrial Science and Technology
- 当前专利权人地址： 3-1, Kasumigaseki 1-chome, Chiyoda-ku Tokyo 100-8921 JP
- 代理机构： HOFFMANN EITLE
- 优先权： JP2003285422 20030801; JP2003369494 20031029
- 国际公布： WO2005011633 20050210
- 主分类号： A61K9/127
- IPC分类号： A61K9/127 ; A61K47/24 ; A61K47/26 ; A61K47/28 ; A61K47/36 ; A61K47/42 ; A61K49/00 ; A61P29/00
摘要：
There is provided targeting drug delivery system (DDS) nanoparticles that can be accumulated in target tissues such as inflammatory sites of inflammatory diseases and can thus be utilized in a therapeutic or diagnostic DDS for locally delivering drugs or genes to the affected parts. The present invention provides a pharmaceutical composition for the medical treatment or diagnosis of an inflammatory disease comprising a sugar-modified liposome having a sugar chain bound to the membrane of the liposome.
信息查询
